GEHC vs INDV: fair value comparison
GE HealthCare Technologies Inc. and Indivior Pharmaceuticals, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, INDV currently sits closer to the top of our discount ranking.
| GEHC | INDV | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $71.72 | $37.37 |
| 12-month range | $61.03–$82.82 | $23.46–$40.25 |
| Sector rank | #34 of 113 Healthcare | #29 of 113 Healthcare |
| Quality grade | F | F |
| Momentum grade | A | — |
| Leverage | Moderate | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: GEHC fair value analysis · INDV fair value analysis